J P Greving

Summary

Affiliation: University Medical Center Utrecht
Country: The Netherlands

Publications

  1. doi request reprint Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
    J P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands
    BMJ 342:d1672. 2011
  2. doi request reprint Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands Electronic address
    Lancet Neurol 13:59-66. 2014
  3. doi request reprint Predicting outcome after acute basilar artery occlusion based on admission characteristics
    J P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    Neurology 78:1058-63. 2012
  4. doi request reprint Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Neurology 73:258-65. 2009
  5. doi request reprint Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Internal mailbox Str 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Gynecol Oncol 113:68-74. 2009
  6. doi request reprint Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands
    Circulation 117:2875-83. 2008
  7. pmc Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
    Cardiovasc Diabetol 6:25. 2007
  8. doi request reprint Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study
    B G Brouwer
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    J Intern Med 268:83-93. 2010
  9. ncbi request reprint Uptake of angiotensin II receptor blockers in the treatment of hypertension
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, PO Box 196, 9700, AD, Groningen, The Netherlands
    Eur J Clin Pharmacol 61:461-6. 2005
  10. doi request reprint Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis
    Marjolein de Weerd
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Internal Mail Str 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Stroke 41:1294-7. 2010

Detail Information

Publications16

  1. doi request reprint Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
    J P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Netherlands
    BMJ 342:d1672. 2011
    ....
  2. doi request reprint Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands Electronic address
    Lancet Neurol 13:59-66. 2014
    ..We combined individual patient data from prospective cohort studies to determine predictors of aneurysm rupture and to construct a risk prediction chart to estimate 5-year aneurysm rupture risk by risk factor status...
  3. doi request reprint Predicting outcome after acute basilar artery occlusion based on admission characteristics
    J P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    Neurology 78:1058-63. 2012
    ..To develop a simple prognostic model to predict outcome at 1 month after acute basilar artery occlusion (BAO) with readily available predictors...
  4. doi request reprint Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Stratenum 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Neurology 73:258-65. 2009
    ....
  5. doi request reprint Is centralization of ovarian cancer care warranted? A cost-effectiveness analysis
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Internal mailbox Str 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Gynecol Oncol 113:68-74. 2009
    ..To evaluate the cost-effectiveness of tertiary referral care for ovarian cancer patients in the Netherlands...
  6. doi request reprint Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk
    Jacoba P Greving
    Julius Center for Health Sciences and Primary Care, Department of Neurology and Neurosurgery, University Medical Center Utrecht, Utrecht, Netherlands
    Circulation 117:2875-83. 2008
    ..We assessed the cost-effectiveness of aspirin separately for men and women of different ages with various levels of cardiovascular disease risk...
  7. pmc Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
    Cardiovasc Diabetol 6:25. 2007
    ..The objective is to assess trends in risk factor treatment, and identify determinants for medication adjustments in patients with uncontrolled hypertension and/or hyperlipidemia...
  8. doi request reprint Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study
    B G Brouwer
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
    J Intern Med 268:83-93. 2010
    ....
  9. ncbi request reprint Uptake of angiotensin II receptor blockers in the treatment of hypertension
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, PO Box 196, 9700, AD, Groningen, The Netherlands
    Eur J Clin Pharmacol 61:461-6. 2005
    ..To examine trends in prescribing of angiotensin II receptor blockers (ARBs) as initial and second-line treatment of hypertension...
  10. doi request reprint Prevalence of asymptomatic carotid artery stenosis in the general population: an individual participant data meta-analysis
    Marjolein de Weerd
    Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Internal Mail Str 6 131, PO Box 85500, 3508 GA Utrecht, The Netherlands
    Stroke 41:1294-7. 2010
    ..Accordingly, we assessed the prevalence of moderate and severe asymptomatic carotid stenosis by age and sex using pooled cohort data...
  11. ncbi request reprint Claims in advertisements for antihypertensive drugs in a Dutch medical journal
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, University of Groningen, The Netherlands
    J Hypertens 25:713-22. 2007
    ..Advertising claims must not conflict with the official summary of product characteristics. After a drug has been approved, new clinical evidence may become available...
  12. ncbi request reprint Determinants for the adoption of angiotensin II receptor blockers by general practitioners
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, The Netherlands
    Soc Sci Med 63:2890-8. 2006
    ..Aside from determinants related to the patient population, adoption of a new drug class among Dutch GPs is still determined more by their reliance on promotional information than by their use of professional information sources...
  13. ncbi request reprint Physicians' attitudes towards treatment guidelines: differences between teaching and nonteaching hospitals
    Jacoba P Greving
    Department of Clinical Pharmacology, University Medical Center Groningen, A Deusinglaan 1, 9713 AV, Groningen, The Netherlands
    Eur J Clin Pharmacol 62:129-33. 2006
    ..To investigate whether physicians' attitudes towards treatment guidelines for primary and secondary care differ between teaching and nonteaching hospitals shortly before and 4 years after the guidelines' introduction...
  14. ncbi request reprint Does comorbidity explain trends in prescribing of newer antihypertensive agents?
    Jacoba P Greving
    Department of Clinical Pharmacology, University of Groningen, The Netherlands
    J Hypertens 22:2209-15. 2004
    ..The association between comorbidity and trends in prescribing of angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor blockers (ARBs) was examined for the period 1996-2000...